Caroline P. Samp

Caroline Samp advises private companies on a wide range of corporate matters, including formation, financings, mergers and acquisitions, and general corporate governance. Caroline also advises public companies with respect to ongoing annual and periodic reporting requirements, Section 16 matters, annual and special stockholder meetings, and Rule 144 compliance and related requests for stock certificate removal.


  • Boston University School of Law, J.D., cum laude, 2015
  • Mount Allison University, B.A., with Distinction, 2009

Bar and Court Admissions

  • Massachusetts


  • Entegris, Inc. (Nasdaq: ENTG) in the acquisition of MPD Chemicals for approximately $16 million
  • Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) in its acquisition of Syntimmune
  • Thermo Fisher Scientific Inc. (NYSE: TMO) in its acquisition of Becton, Dickinson and Company’s Advanced Bioprocessing business
  • Applied Genetic Technologies Corporation (Nasdaq: AGTC) in its sales agreement with Cantor Fitzgerald & Co. for an up to $25 million ATM offering
  • Zosano Pharma Corporation (Nasdaq: ZSAN):
    • $50 million underwritten public offering of common stock
    • $29.3 million underwritten public offering of common stock
  • Acer Therapeutics in its merger with Opexa Therapeutics
  • Nelson Properties Limited, a portfolio company managed by Global Forest Partners LP, in the sale of its subsidiary, Nelson Forests Limited, one of New Zealand's leading forestry businesses, to Australian forestry company OneFortyOne Plantations
  • Dell EMC in the sale of EMC’s enterprise content division to Open Text Corporation (Nasdaq: OTEX) (TSX: OTC) for $1.62 billion

Honors & Involvement

  • The Best Lawyers in America: Ones to Watch 
  • Boston Bar Association, Member